Physician profile
Amanda Hunt
NPI 1023614377
$1,254.58
in general payments reported to CMS, 2019-2025
21 companies · $20.49 in 2025
The $20.49 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $823 · 2022: $393 · 2023: $18.40 · 2025: $20.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $182.63 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.86 | 2021 | |
| Amgen INC. | $117.33 | 2021-2022 | |
| Medtronic, INC. | $115.00 | 2021 | |
| Abbvie INC. | $107.87 | 2021 | |
| Amarin Pharma, INC. | $88.47 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $64.28 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.82 | 2021 | |
| Novartis Pharmaceuticals Corporation | $56.15 | 2022-2025 | |
| Lilly USA, LLC | $48.15 | 2021-2022 | |
| Novo Nordisk INC | $47.66 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $40.18 | 2022 | |
| Corium, LLC | $34.33 | 2021-2022 | |
| Esperion Therapeutics, INC. | $33.52 | 2021 | |
| Lundbeck LLC | $27.36 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $20.39 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.44 | 2022 | |
| Glaxosmithkline, LLC. | $17.30 | 2022 | |
| Organon LLC | $16.34 | 2022 | |
| Currax Pharmaceuticals LLC | $15.71 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.